BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22705497)

  • 1. Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research.
    Pasquini MC; Voltarelli J; Atkins HL; Hamerschlak N; Zhong X; Ahn KW; Sullivan KM; Carrum G; Andrey J; Bredeson CN; Cairo M; Gale RP; Hahn T; Storek J; Horowitz MM; McSweeney PA; Griffith LM; Muraro PA; Pavletic SZ; Nash RA
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1471-8. PubMed ID: 22705497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases.
    Farge D; Labopin M; Tyndall A; Fassas A; Mancardi GL; Van Laar J; Ouyang J; Kozak T; Moore J; Kötter I; Chesnel V; Marmont A; Gratwohl A; Saccardi R
    Haematologica; 2010 Feb; 95(2):284-92. PubMed ID: 19773265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous hematopoietic stem cell transplantation for autoimmune disease--is it now ready for prime time?
    Atkins HL; Muraro PA; van Laar JM; Pavletic SZ
    Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S177-83. PubMed ID: 22226104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016.
    Passweg JR; Baldomero H; Ansari M; Baerlocher GM; Bargetzi M; Chalandon Y; Duchosal MA; Gerull S; Güngör T; Halter JP; Heim D; Hess U; Leibundgut K; Masouridi-Levrat S; Müller A; Nair G; Pabst T; Renner C; Schmidt A; Stussi G; Nicoloso de Faveri G; Schanz U; For The Swiss Blood Stem Cell Transplantation Group Sbst
    Swiss Med Wkly; 2018; 148():w14589. PubMed ID: 29493715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
    El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
    Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases.
    Thakar MS; Broglie L; Logan B; Artz A; Bunin N; Burroughs LM; Fretham C; Jacobsohn DA; Loren AW; Kurtzberg J; Martinez CA; Mineishi S; Nelson AS; Woolfrey A; Pasquini MC; Sorror ML
    Blood; 2019 Feb; 133(7):754-762. PubMed ID: 30545834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous and allogeneic transplantation for burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant research.
    Maramattom LV; Hari PN; Burns LJ; Carreras J; Arcese W; Cairo MS; Costa LJ; Fenske TS; Lill M; Freytes CO; Gale RP; Gross TG; Hale GA; Hamadani M; Holmberg LA; Hsu JW; Inwards DJ; Lazarus HM; Marks DI; Maloney DG; Maziarz RT; Montoto S; Rizzieri DA; Wirk B; Gajewski JL
    Biol Blood Marrow Transplant; 2013 Feb; 19(2):173-9. PubMed ID: 23200705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Global State of Hematopoietic Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation Database and the Global Burden of Disease Study.
    Cowan AJ; Baldomero H; Atsuta Y; Mikhael J; Aljurf M; Seber A; Greinix H; Koh M; Worel N; Libby EN; Pasquini M; Galeano S; Saber W; Iida M; Jaimovich G; Rolon JM; Kodera Y; Benakli M; Nosa BG; Elhaddad A; Szer J; Passweg J; Kroeger N; Weisdorf D; Niederwieser D
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2372-2377. PubMed ID: 32846200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates.
    Nivison-Smith I; Simpson JM; Dodds AJ; Ma DD; Szer J; Bradstock KF
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1323-30. PubMed ID: 19747641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.
    Lazarus HM; Zhang MJ; Carreras J; Hayes-Lattin BM; Ataergin AS; Bitran JD; Bolwell BJ; Freytes CO; Gale RP; Goldstein SC; Hale GA; Inwards DJ; Klumpp TR; Marks DI; Maziarz RT; McCarthy PL; Pavlovsky S; Rizzo JD; Shea TC; Schouten HC; Slavin S; Winter JN; van Besien K; Vose JM; Hari PN
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):35-45. PubMed ID: 20053330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in use of and survival after autologous hematopoietic cell transplantation in North America, 1995-2005: significant improvement in survival for lymphoma and myeloma during a period of increasing recipient age.
    McCarthy PL; Hahn T; Hassebroek A; Bredeson C; Gajewski J; Hale G; Isola L; Lazarus HM; Lee SJ; Lemaistre CF; Loberiza F; Maziarz RT; Rizzo JD; Joffe S; Parsons S; Majhail NS
    Biol Blood Marrow Transplant; 2013 Jul; 19(7):1116-23. PubMed ID: 23660172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Loss to Follow-Up Among Pediatric and Adult Hematopoietic Cell Transplantation Survivors: A Report from the Center for International Blood and Marrow Transplant Research.
    Buchbinder D; Brazauskas R; Bo-Subait K; Ballen K; Parsons S; John T; Hahn T; Sharma A; Steinberg A; D'Souza A; Kumar AJ; Yoshimi A; Wirk B; Shaw B; Freytes C; LeMaistre C; Bredeson C; Dandoy C; Almaguer D; Marks DI; Szwajcer D; Hale G; Schouten H; Hashem H; Schoemans H; Murthy HS; Lazarus HM; Cerny J; Tay J; Yared JA; Adekola K; Schultz KR; Lehmann L; Burns L; Aljurf M; Diaz MA; Majhail N; Farhadfar N; Kamble R; Olsson R; Schears R; Seo S; Beattie S; Chhabra S; Savani BN; Badawy S; Ganguly S; Ciurea S; Marino S; Gergis U; Kuwatsuka Y; Inamoto Y; Khera N; Hashmi S; Wood W; Saber W
    Biol Blood Marrow Transplant; 2020 Mar; 26(3):553-561. PubMed ID: 31726205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic cell transplantation for benign hematological disorders and solid tumors.
    Storb RF; Lucarelli G; McSweeney PA; Childs RW
    Hematology Am Soc Hematol Educ Program; 2003; ():372-97. PubMed ID: 14633791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.
    Tomblyn MR; Ewell M; Bredeson C; Kahl BS; Goodman SA; Horowitz MM; Vose JM; Negrin RS; Laport GG
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1051-7. PubMed ID: 21073974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation.
    Kliman D; Nivison-Smith I; Gottlieb D; Hamad N; Kerridge I; Purtill D; Szer J; Ma D
    Biol Blood Marrow Transplant; 2020 Sep; 26(9):1711-1718. PubMed ID: 32194285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell transplantation for severe autoimmune diseases: progress and problems.
    Marmont AM
    Haematologica; 1998 Aug; 83(8):733-43. PubMed ID: 9793258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery.
    Kalwak K; Gorczyńska E; Toporski J; Turkiewicz D; Slociak M; Ussowicz M; Latos-Grazyńska E; Król M; Boguslawska-Jaworska J; Chybicka A
    Br J Haematol; 2002 Jul; 118(1):74-89. PubMed ID: 12100130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful.
    Shaw BE; Brazauskas R; Millard HR; Fonstad R; Flynn KE; Abernethy A; Vogel J; Petroske C; Mattila D; Drexler R; Lee SJ; Horowitz MM; Rizzo JD
    Cancer; 2017 Dec; 123(23):4687-4700. PubMed ID: 28817182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 Trial.
    Giralt S; Costa LJ; Maloney D; Krishnan A; Fei M; Antin JH; Brunstein C; Geller N; Goodman S; Hari P; Logan B; Lowsky R; Qazilbash MH; Sahebi F; Somlo G; Rowley S; Vogl DT; Vesole DH; Pasquini M; Stadtmauer E
    Biol Blood Marrow Transplant; 2020 Apr; 26(4):798-804. PubMed ID: 31756536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic cell transplantation for autoimmune disease: updates from Europe and the United States.
    Sullivan KM; Muraro P; Tyndall A
    Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S48-56. PubMed ID: 19895895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.